An observational study in Brain Injuries, Acute, sponsored by Mario Negri Institute for Pharmacological Research. Recruiting at 27 sites in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by Mario Negri Institute for Pharmacological Research · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 76 studies in Brain Injuries with a site in Italy — 27 open to participants now, 29 under way, none of them phase 3. Brain Injuries · Italy.
Among the 76 studies in Brain Injuries with a site in Italy, this one has the largest planned enrollment of the 28 observational ones that give a count, is one of 3 that started in 2022, is one of 28 observational ones, reaches primary completion later than 20 of the 28 other live ones, and was the 35th registered.
947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.
Browse Brain Injuries studies →27 of the 76 studies in Brain Injuries with a site in Italy are open now. Recruiting first, the newest first:
Fondazione Don Carlo Gnocchi ETS · Sites in Italy
Ages 18+
Alfonso Magliacano · Sites in Italy
Ages 18–75 · Healthy volunteers
IRCCS Eugenio Medea · Sites in Italy
Ages 6–14
Fondazione Don Carlo Gnocchi ETS · Sites in Italy
Ages 18–80
Istituti Clinici Scientifici Maugeri SpA · Sites in Italy
Ages 18–80
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 152 Brain Injuries studies recruiting now, 77 (51%) set no upper age limit and 53 (35%) stop at 75 or younger; 38 take children under 18; 23 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
76 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 3 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 2,500 is above the median of 100 across 302 observational studies indexed under Brain Injuries.
Median enrollment 40 across the 48 interventional studies, 88 across the 28 observational. Of the 35 that completed or were terminated, 2 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 76 have an industry lead sponsor. The 10 most frequent:
Mario Negri Institute for Pharmacological Research is the lead sponsor of 161 studies on the registry; 38 are open to participants now.
Mario Negri Institute for Pharmacological Research has 1 study filed under Brain Injuries — fewer than ten, so there is no comparison to draw.
7 of the studies in Brain Injuries with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06823193Istituti Clinici Scientifici Maugeri SpAThe Impact of Self-processing on Mental Time Travel | 2026-12-30 |
| NCT07490418B&B srlTES HT100 Clinical Validation for Brain Injury Screening in Patients With Mild Head Trauma or Neurological Symptoms | 2026-12-30 |
| NCT06873477Fondazione Policlinico Universitario Agostino Gemelli IRCCSEvaluation of Patients Affected by Traumatic and Hypoxic-ischemic Brain Injury | 2027-01-31 |
| NCT05493514Fondazione Don Carlo Gnocchi OnlusClinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System | 2027-04-01 |
| NCT04905264Mario Negri Institute for Pharmacological ResearchSevere Acquired Brain Injuries: Prognostic Factors and Quality of Care | 2027-06 |
Add all 7 to your calendar (.ics) → With an account.
Among the 76 studies in Brain Injuries with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The main purpose of this project is to identify the medium-term prognostic factors for patients with Severe Acquired Brain Injuries and evaluate their impact.
The secondary aim is to create a system of continuous assessment of the quality of care for each rehabilitation unit.
For each unit involved, it will be collected these data :
Statistical models will be implemented, in order to identify prognostic factors that could predict the probability to observe three events, which represent objectives of the rehabilitation process: decannulation, trunk control and total feeding by os. These events should be evaluated four months after the acute episode.
All patients admitted in the Rehabilitation Units for Severe Acquired Brain Injuries participating in the study during the 30 months of enrollment provided by the research
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
- patients admitted more than 14 weeks after the acute event
Adults admitted in study's participants Rehabilitation Units for Severe Acquired Brain Injuries from the 1st of July 2021 to the 31st of December 2023. Patients entered into these units more than 14 weeks after the acute event are excluded
Tracheostomy tube
Removal of the tracheostomy tube, which is considered successful if the patient is not to be re-cannulated within 7 days
Time frame: july 2021 - june 2025
Trunk control
Achievement of trunk control, for which the patient must be able to maintain the sitting position for at least 60 seconds, on a rigid surface, with the lower limbs in support, but without support from the upper limbs and without rear support of the trunk
Time frame: july 2021 - june 2025
Total feeeding by os
Oral feeding with sufficient caloric intake
Time frame: july 2021 - june 2025
Not enrolling at this site — choose another above.
Plan to share: Undecided — Protecting the privacy policy, all the data that underlie results in a publication will be shared. The scientific commettee of the study has to decide the criteria and the best way to share them
Started Jan 2022 (actual). Primary completion is estimated for Jun 2027, 65 months after the start.
Of 144 non-industry observational studies under Brain Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 73. This study's planned 65 months is above that.
Counting every sponsor, half of 149 studies reached it within 31 months; a quarter within 16 and three quarters within 73.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mario Negri Institute for Pharmacological Research →